Hextar Healthcare Berhad (KLSE:HEXCARE)
0.1100
-0.0050 (-4.35%)
At close: Jun 4, 2025
Hextar Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 144.25 | 146.95 | 154.76 | 174.97 | 509.95 | 415.15 | Upgrade
|
Other Revenue | 2.75 | 2.75 | 2.15 | 5.42 | 4.72 | 1.5 | Upgrade
|
Revenue | 147 | 149.7 | 156.91 | 180.38 | 514.67 | 416.64 | Upgrade
|
Revenue Growth (YoY) | -10.81% | -4.60% | -13.01% | -64.95% | 23.53% | 89.82% | Upgrade
|
Cost of Revenue | 82.25 | 80.7 | 99.53 | 123.17 | 160.09 | 158.91 | Upgrade
|
Gross Profit | 64.75 | 69.01 | 57.39 | 57.21 | 354.58 | 257.74 | Upgrade
|
Selling, General & Admin | 33.63 | 34.28 | 39.88 | 37.73 | 48.16 | 40.81 | Upgrade
|
Other Operating Expenses | 38.62 | 37.67 | 61.16 | 47.55 | 63.13 | 43.28 | Upgrade
|
Operating Expenses | 89.22 | 88.92 | 120.52 | 100.21 | 124.62 | 92.92 | Upgrade
|
Operating Income | -24.47 | -19.92 | -63.14 | -43 | 229.96 | 164.82 | Upgrade
|
Interest Expense | -0.3 | -0.27 | -0.5 | -0.2 | -0.1 | -0.27 | Upgrade
|
Interest & Investment Income | 0.08 | 0.08 | 0.03 | 0.01 | 0.01 | 0.01 | Upgrade
|
Earnings From Equity Investments | -2.21 | -2.34 | -0.09 | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -2.25 | -2.25 | 0.15 | -0.11 | 1.71 | 0.49 | Upgrade
|
Other Non Operating Income (Expenses) | -0.26 | -0.26 | -0.31 | -0.41 | -0.33 | -0.32 | Upgrade
|
EBT Excluding Unusual Items | -29.41 | -24.95 | -63.85 | -43.71 | 231.25 | 164.74 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 0.02 | -0.02 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.19 | -0.19 | -1.22 | -0.03 | 5.95 | -1.33 | Upgrade
|
Asset Writedown | -0.27 | -0.27 | -8.58 | -20 | -0.42 | -2.37 | Upgrade
|
Other Unusual Items | 6.43 | 6.43 | -0.02 | 0.58 | - | - | Upgrade
|
Pretax Income | -23.43 | -18.98 | -73.64 | -63.18 | 236.78 | 161.04 | Upgrade
|
Income Tax Expense | -5.38 | -5.06 | -9.26 | -7.49 | 51.04 | 29.86 | Upgrade
|
Earnings From Continuing Operations | -18.05 | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
Net Income | -18.05 | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
Net Income to Common | -18.05 | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
Net Income Growth | - | - | - | - | 41.60% | 394.81% | Upgrade
|
Shares Outstanding (Basic) | 1,059 | 1,045 | 1,002 | 895 | 852 | 803 | Upgrade
|
Shares Outstanding (Diluted) | 1,059 | 1,045 | 1,002 | 895 | 852 | 803 | Upgrade
|
Shares Change (YoY) | 4.59% | 4.28% | 11.94% | 5.08% | 6.13% | 6.08% | Upgrade
|
EPS (Basic) | -0.02 | -0.01 | -0.06 | -0.06 | 0.22 | 0.16 | Upgrade
|
EPS (Diluted) | -0.02 | -0.01 | -0.06 | -0.06 | 0.22 | 0.16 | Upgrade
|
EPS Growth | - | - | - | - | 33.42% | 366.46% | Upgrade
|
Free Cash Flow | -11.27 | -22.4 | -28.74 | -34.96 | 99.09 | 79.7 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.02 | -0.03 | -0.04 | 0.12 | 0.10 | Upgrade
|
Gross Margin | 44.05% | 46.10% | 36.57% | 31.71% | 68.89% | 61.86% | Upgrade
|
Operating Margin | -16.65% | -13.30% | -40.24% | -23.84% | 44.68% | 39.56% | Upgrade
|
Profit Margin | -12.28% | -9.30% | -41.03% | -30.87% | 36.09% | 31.48% | Upgrade
|
Free Cash Flow Margin | -7.66% | -14.96% | -18.32% | -19.38% | 19.25% | 19.13% | Upgrade
|
EBITDA | -9.41 | -4.42 | -45.91 | -28.57 | 242.47 | 172.8 | Upgrade
|
EBITDA Margin | -6.40% | -2.95% | -29.26% | -15.84% | 47.11% | 41.47% | Upgrade
|
D&A For EBITDA | 15.06 | 15.49 | 17.23 | 14.43 | 12.51 | 7.98 | Upgrade
|
EBIT | -24.47 | -19.92 | -63.14 | -43 | 229.96 | 164.82 | Upgrade
|
EBIT Margin | -16.65% | -13.30% | -40.24% | -23.84% | 44.68% | 39.56% | Upgrade
|
Effective Tax Rate | - | - | - | - | 21.56% | 18.54% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.